Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T cell response
Falkenburg, J. H. Frederik
- 1Leiden University - Excl LUMC
- 2Leiden University
- 3
Journal
Journal of Clinical Investigation
ISSN
0021-9738
1558-8238
Open Access
bronze
Volume
127
Start page
517
End page
529
Patients with leukemia who receive a T cell-depleted allogeneic stem cell graft followed by postponed donor lymphocyte infusion (DLI) can experience graft-versus-leukemia (GVL) reactivity, with a lower risk of graft-versus-host disease (GVHD). Here, we have investigated the magnitude, diversity, and specificity of alloreactive CD8 T cells in patients who developed GVL reactivity after DLI in the absence or presence of GVHD. We observed a lower magnitude and diversity of CD8 T cells for minor histocompatibility antigens (MiHAs) in patients with selective GVL reactivity without GVHD. Furthermore, we demonstrated that MiHA-specific T cell clones from patients with selective GVL reactivity showed lower reactivity against nonhematopoietic cells, even when pretreated with inflammatory cytokines. Expression analysis of MiHA-encoding genes showed that similar types of antigens were recognized in both patient groups, but in patients who developed GVHD, T cell reactivity was skewed to target broadly expressed MiHAs. As an inflammatory environment can render nonhematopoietic cells susceptible to T cell recognition, prevention of such circumstances favors induction of selective GVL reactivity without development of GVHD.
Name
jci-127-86175.pdf
Size
758.87 KB
Format
Adobe PDF
Checksum
(MD5):9888e0d14318b00cced05711bac73e5c